Australian Crohn's antibiotic study opens new horizons

Gastroenterology. 2007 Nov;133(5):1743-4; author reply 1745-6. doi: 10.1053/j.gastro.2007.09.014.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage
  • Clarithromycin / administration & dosage
  • Clofazimine / administration & dosage
  • Crohn Disease / drug therapy*
  • Crohn Disease / virology*
  • Drug Therapy, Combination
  • Gastrointestinal Agents / administration & dosage
  • Humans
  • Infliximab
  • Mycobacterium avium subsp. paratuberculosis / pathogenicity*
  • Paratuberculosis / complications*
  • Paratuberculosis / drug therapy
  • Randomized Controlled Trials as Topic
  • Remission Induction
  • Reproducibility of Results
  • Rifabutin / administration & dosage
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Rifabutin
  • Infliximab
  • Clofazimine
  • Clarithromycin